In conclusion the novel Hgf-Cdk4R24C autochthonous urothelial cancer model and cell lines should be utilized to further understand the immuno-biology implications of tumor subtype and biological sex on therapeutic immune modulation in bladder cancer. This evidence concerns the gene HGF and urinary bladder cancer.